← brief for 2026-10-10 · Slowing decline
Anti-PLA2R antibody levels and clinical risk factors for predicting relapse in primary membranous nephropathy
Key takeaways
This study looks at blood tests to predict if a kidney disease will come back. There is no abstract, so we do not have the results yet. It is a study that is starting or planned.
Who did this work
Wang H (Department of Nephrology, Jining No.1 People’s Hospital , , ) · Ma H (Department of Nephrology, Jining No.1 People’s Hospital , , ) · Wang H (Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine , , )
Source
Article · Europe PMC, CKD · 2026-10-10
https://europepmc.org/article/PMC/PMC13649681